-
Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insights
- 2024/12/09
- 再生時間: 6 分
- ポッドキャスト
-
サマリー
あらすじ・解説
On Day 2 of ASH 2024, we explore breakthroughs in treating high-risk smoldering multiple myeloma, advancements in chronic lymphocytic leukemia therapies, and a revealing study on leukemia risk in Ground Zero first responders. Stay updated with insights that are reshaping hematology practice.
Love what you hear? Download the Curie app for daily updates and bonus episodes tailored for oncology professionals.